Cargando…
TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration
To investigate the visual and anatomical impact of intravitreal injection treatment deferral because of the COVID-19 lockdown on patients affected by neovascular age-related macular degeneration. METHODS: We retrospectively reviewed 314 patients (394 eyes) who were scheduled to receive the impact of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946588/ https://www.ncbi.nlm.nih.gov/pubmed/34907122 http://dx.doi.org/10.1097/IAE.0000000000003369 |
_version_ | 1784674229767110656 |
---|---|
author | Montesel, Andrea Gigon, Anthony Giacuzzo, Clarice Mantel, Irmela Eandi, Chiara M. |
author_facet | Montesel, Andrea Gigon, Anthony Giacuzzo, Clarice Mantel, Irmela Eandi, Chiara M. |
author_sort | Montesel, Andrea |
collection | PubMed |
description | To investigate the visual and anatomical impact of intravitreal injection treatment deferral because of the COVID-19 lockdown on patients affected by neovascular age-related macular degeneration. METHODS: We retrospectively reviewed 314 patients (394 eyes) who were scheduled to receive the impact of intravitreal injections during the Swiss lockdown. We compared patients who continued to receive scheduled impact of intravitreal treatment without clinical consultation (Group Continue ‟C”; n = 215) and patients for whom the impact of intravitreal treatment was completely deferred (Group Stop, ‟S”; n = 179). Functional and anatomical parameters were collected at four time points before and after the lockdown. RESULTS: In Group C, the visual acuity at baseline and after the lockdown did not differ significantly. In Group S, the visual acuity deteriorated significantly compared with baseline and then improved slightly after the resumption of treatment, but it did not recover to baseline values. The mean central subfield thickness remained stable in Group C, whereas it increased in Group S and then returned to prelockdown values after the resumption of treatment. CONCLUSION: An “injection-only” approach was effective in managing patients with neovascular age-related macular degeneration during the pandemic lockdown, whereas patients who deferred their scheduled treatment showed partially irreversible deterioration of visual function. We recommend treatment continuation in patients with neovascular age-related macular degeneration during a lockdown. |
format | Online Article Text |
id | pubmed-8946588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Retina |
record_format | MEDLINE/PubMed |
spelling | pubmed-89465882022-04-01 TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration Montesel, Andrea Gigon, Anthony Giacuzzo, Clarice Mantel, Irmela Eandi, Chiara M. Retina Original Study To investigate the visual and anatomical impact of intravitreal injection treatment deferral because of the COVID-19 lockdown on patients affected by neovascular age-related macular degeneration. METHODS: We retrospectively reviewed 314 patients (394 eyes) who were scheduled to receive the impact of intravitreal injections during the Swiss lockdown. We compared patients who continued to receive scheduled impact of intravitreal treatment without clinical consultation (Group Continue ‟C”; n = 215) and patients for whom the impact of intravitreal treatment was completely deferred (Group Stop, ‟S”; n = 179). Functional and anatomical parameters were collected at four time points before and after the lockdown. RESULTS: In Group C, the visual acuity at baseline and after the lockdown did not differ significantly. In Group S, the visual acuity deteriorated significantly compared with baseline and then improved slightly after the resumption of treatment, but it did not recover to baseline values. The mean central subfield thickness remained stable in Group C, whereas it increased in Group S and then returned to prelockdown values after the resumption of treatment. CONCLUSION: An “injection-only” approach was effective in managing patients with neovascular age-related macular degeneration during the pandemic lockdown, whereas patients who deferred their scheduled treatment showed partially irreversible deterioration of visual function. We recommend treatment continuation in patients with neovascular age-related macular degeneration during a lockdown. Retina 2022-04 2021-12-02 /pmc/articles/PMC8946588/ /pubmed/34907122 http://dx.doi.org/10.1097/IAE.0000000000003369 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Study Montesel, Andrea Gigon, Anthony Giacuzzo, Clarice Mantel, Irmela Eandi, Chiara M. TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title | TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title_full | TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title_fullStr | TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title_full_unstemmed | TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title_short | TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration |
title_sort | treatment deferral during covid-19 lockdown: functional and anatomical impact on patients with neovascular age-related macular degeneration |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946588/ https://www.ncbi.nlm.nih.gov/pubmed/34907122 http://dx.doi.org/10.1097/IAE.0000000000003369 |
work_keys_str_mv | AT monteselandrea treatmentdeferralduringcovid19lockdownfunctionalandanatomicalimpactonpatientswithneovascularagerelatedmaculardegeneration AT gigonanthony treatmentdeferralduringcovid19lockdownfunctionalandanatomicalimpactonpatientswithneovascularagerelatedmaculardegeneration AT giacuzzoclarice treatmentdeferralduringcovid19lockdownfunctionalandanatomicalimpactonpatientswithneovascularagerelatedmaculardegeneration AT mantelirmela treatmentdeferralduringcovid19lockdownfunctionalandanatomicalimpactonpatientswithneovascularagerelatedmaculardegeneration AT eandichiaram treatmentdeferralduringcovid19lockdownfunctionalandanatomicalimpactonpatientswithneovascularagerelatedmaculardegeneration |